Condensed Consolidated Interim Statements of Operations and Comprehensive Loss - USD ($)
 3 Months Ended 12 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Mar. 31, 2018
Mar. 31, 2017
Sales $ 501,333 $ 87,520 $ 987,431 $ 571,945
Cost of Sales 253,163 29,300 402,665 388,756
Gross Margin 248,170 58,220 584,766 183,189
Operating expenses        
Sales and marketing 542,659 445,525 1,989,837 1,188,207
Research and development 676,743 685,909 2,825,200 2,663,146
General and administrative 979,479 627,606 3,585,484 3,346,230
Share-based compensation expense (Note 11) 595,412 251,048 1,540,580 1,001,950
Amortization (Note 4) 71,053 92,949 323,905 550,080
Depreciation (Note 7) 17,595 24,552 89,026 79,868
Total operating expenses 2,882,941 2,127,589 10,354,032 8,829,481
Other (income) expense        
Foreign exchange (41,134) 98,561 102,999 71,573
Accretion expense (Note 8) 134,251 0 1,937,308 0
Fair value adjustment (Note 8) 44,087 0    
Interest expense (Note 8)     1,297,205 43,735
Share premium (Note 8)     1,249,994 0
(Gain) loss on market to market revaluation (2,048,697) 0 376,674 0
Other expense 37,420 72,588    
Other income     (107,656) (692,198)
Total other (income) expenses (1,874,073) 171,149 4,856,524 (576,890)
Net loss and comprehensive loss for the period $ (760,698) $ (2,240,518) $ (14,625,790) $ (8,069,402)
Loss per share - basic and diluted (Note 16)     $ (0.14) $ (0.09)
Weighted average number of shares outstanding - basic and diluted (Note 16)     100,980,341 91,784,976
Loss per share – basic $ 0.00 $ (0.02) $ (0.14) $ (0.09)
Loss per share – diluted $ 0.00 $ (0.02) $ (0.14) $ (0.09)
Weighted average number of shares outstanding – basic 257,509,141 96,959,284    
Weighted average number of shares outstanding – diluted 257,509,141 96,959,284